Potassium Phosphates Injection
NDC Package 70121-1722-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Potassium Phosphates (potassium phosphates in sodium chloride) injection is potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated. This formulation utilizes a injection delivery system. Marketed by Amneal Pharmaceuticals Llc, this product is identified by NDC 70121-1722 and is authorized under FDA application NDA218343.

Identification & Billing

NDC Package Code
70121-1722-9
Package Description
24 POUCH in 1 CARTON / 1 BAG in 1 POUCH / 250 mL in 1 BAG
Product Code
70121-1722
11-Digit Billing Format
70121172209
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 2688947 - potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 250 ML Injection
  • RxCUI: 2688947 - 250 ML dibasic potassium phosphate 4.72 MG/ML / monobasic potassium phosphate 4.48 MG/ML Injection
  • RxCUI: 2688947 - 250 ML dibasic K+ phosphate 4.72 MG/ML / monobasic K+ phosphate 4.48 MG/ML Injection
  • RxCUI: 2688947 - 250 ML dibasic Pot phosphate 4.72 MG/ML / monobasic Pot phosphate 4.48 MG/ML Injection
  • RxCUI: 2688947 - phosphorus 15 MMOL / potassium 22 MEQ per 250 ML Injection

Clinical Specifications

Proprietary Name
Potassium Phosphates
Non-Proprietary Name
Potassium Phosphates In Sodium Chloride
Substance Name
Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated.

Regulatory & Marketing

Labeler Name
Amneal Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
NDA218343
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-30-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70121-1722-9 identifies a specific commercial package of 24 pouch in 1 carton / 1 bag in 1 pouch / 250 ml in 1 bag of Potassium Phosphates, a human prescription drug labeled by Amneal Pharmaceuticals Llc. This injection is formulated for intravenous use and contains potassium phosphate, dibasic; potassium phosphate, monobasic as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amneal Pharmaceuticals Llc on July 30, 2024. The current certification is valid through December 31, 2026.

How is this Amneal Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70121172209. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70121-1722-9
11-Digit CMS (5-4-2)
70121-1722-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.